MedTech Innovator Selected to Lead the Diagnostics and Medical Devices Hub of the BARDA Accelerator NetworkSeptember 1, 2026
General Newly developed radiotheranostic pair identifies and treats renal tumorsBy Healthcare Propulsion StaffAugust 28, 20260 A newly developed radiotheranostic pair, 68Ga/177Lu-NYM096, can identify tumors and effectively deliver targeted radiotherapy to patients with metastatic clear cell renal cell carcinoma (ccRCC). Using…